NASDAQ:BLCM Investor Notice: Investigation over Potential Wrongdoing by Bellicum Pharmaceuticals Inc
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Bellicum Pharmaceuticals Inc.
View full press release